Home » Stocks » CCEL

Cryo-Cell International Inc. (CCEL)

Stock Price: $8.50 USD 0.00 (-0.03%)
Updated May 6, 2021 10:53 AM EDT - Market open
Market Cap 67.84M
Revenue (ttm) 30.39M
Net Income (ttm) 3.63M
Shares Out 7.57M
EPS (ttm) 0.45
PE Ratio 18.89
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day May 6
Last Price $8.50
Previous Close $8.50
Change ($) 0.00
Change (%) -0.03%
Day's Open 8.55
Day's Range 8.50 - 8.60
Day's Volume 8,239
52-Week Range 6.31 - 10.10


OLDSMAR, Fla., April 14, 2021 (GLOBE NEWSWIRE) -- Cryo-Cell International, Inc. (OTC:QB Markets Group Symbol: CCEL) (the “Company”), the world's first private cord blood bank to separate and store stem ...

3 weeks ago - GlobeNewsWire

About CCEL

Cryo-Cell International, Inc. engages in the cellular processing and cryogenic cellular storage with a focus on the collection and preservation of umbilical cord blood stem cells for family use. It provides cord tissue service that stores a section of the umbilical cord tissue, a source of mesenchymal stem cells that are used in regenerative medicine to treat a range of conditions, including heart, kidney, ALS, wound healing, and auto-immune diseases. The company also manufactures and sells PrepaCyte CB processing system, a technology used to p... [Read more...]

Medical Care Facilities
IPO Date
Jan 21, 1997
Stock Exchange
Ticker Symbol
Full Company Profile

Financial Performance

In 2020, CCEL's revenue was $31.15 million, a decrease of -2.10% compared to the previous year's $31.82 million. Earnings were $3.62 million, an increase of 58.23%.

Financial Statements